Global Female Contraceptive Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Female Contraceptive Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Female contraceptives, also known as female birth control are methods of preventing pregnancy that primarily involve the female physiology.
Female Contraceptive report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Female Contraceptive market is projected to reach US$ 22120 million in 2034, increasing from US$ 18390 million in 2022, with the CAGR of 2.6% during the period of 2024 to 2034. Demand from Online Stores and Retail Outlets are the major drivers for the industry.
Female contraceptive devices account for major shares of the contraceptive pills market throughout the forecast period. The increasing adoption of female contraceptive devices will drive the growth of this product segment in the female contraceptive market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Female Contraceptive market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Merck
Pfizer
Allergan
Bayer
Okamoto Industries
Reckitt Benckiser
Lupin Pharmaceuticals
Foundation Consumer Healthcare
Teva Pharmaceuticals
Ansell
Ferring Pharmaceuticals
Fuji Latex
Janssen Pharmaceuticals
Segment by Type
Female Contraceptive Devices
Female Contraceptive Drugs
Online Stores
Retail Outlets
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Female Contraceptive market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Female Contraceptive, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Female Contraceptive industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Female Contraceptive in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Female Contraceptive introduction, etc. Female Contraceptive Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Female Contraceptive market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Female Contraceptive report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Female Contraceptive market is projected to reach US$ 22120 million in 2034, increasing from US$ 18390 million in 2022, with the CAGR of 2.6% during the period of 2024 to 2034. Demand from Online Stores and Retail Outlets are the major drivers for the industry.
Female contraceptive devices account for major shares of the contraceptive pills market throughout the forecast period. The increasing adoption of female contraceptive devices will drive the growth of this product segment in the female contraceptive market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Female Contraceptive market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Merck
Pfizer
Allergan
Bayer
Okamoto Industries
Reckitt Benckiser
Lupin Pharmaceuticals
Foundation Consumer Healthcare
Teva Pharmaceuticals
Ansell
Ferring Pharmaceuticals
Fuji Latex
Janssen Pharmaceuticals
Segment by Type
Female Contraceptive Devices
Female Contraceptive Drugs
Segment by Application
Online Stores
Retail Outlets
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Female Contraceptive market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Female Contraceptive, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Female Contraceptive industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Female Contraceptive in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Female Contraceptive introduction, etc. Female Contraceptive Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Female Contraceptive market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.